Paper I
2025 March (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

Losartan.

Q33 marksShort Notes

Answer

Losartan is an angiotensin II receptor blocker (ARB).

MOA: losartanselectively blocks AT1 receptors → prevents angiotensin II-mediated vasoconstriction and aldosterone secretion → ↓peripheral resistance, ↓sodium/water retention. Unlike ACE inhibitors, does not affect bradykinin metabolism.

Uses: hypertension, heart failure, diabetic nephropathy — particularly in patients who cannot tolerate ACE inhibitors.

Adverse effects: generally well tolerated; no dry cough (bradykinin spared, the key advantage over ACE inhibitors), hyperkalemia, first-dose hypotension, teratogenicity (contraindicated in pregnancy). Losartan specifically also has a uricosuric effect, useful in hypertensive patients with hyperuricemia.

Other Years Asked


Revise MBBS
Preview